Catalent
CTLT
#1568
Rank
โ‚น934.24 B
Marketcap
โ‚น5,147
Share price
2.21%
Change (1 day)
55.57%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -โ‚น105.61

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น108.88. In 2022 the company made an earnings per share (EPS) of โ‚น191.60 a decrease over its 2021 EPS that were of โ‚น276.00.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น105.61-155.12%
2022โ‚น191.60-30.58%
2021โ‚น276.0079.67%
2020โ‚น153.62114.12%
2019โ‚น71.74-15%
2018โ‚น84.4075.44%
2017โ‚น48.11-22.97%
2016โ‚น62.46-59.56%
2015โ‚น154.46282.05%
2014โ‚น40.43-378.2%
2013-โ‚น14.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น66.68-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น63.30-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น119.01 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น539.35-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA